Huons Global Overview
- Year Founded
-
1965
- Status
-
Public
- Employees
-
121
- Stock Symbol
-
084110
- Investments
-
24
- Share Price
-
$39.36
- (As of Thursday Closing)
Huons Global General Information
Description
Huons Global Co Ltd is active in the healthcare sector. Its primary business includes the manufacture and sale of pharmaceutical products. The company functions through three divisions; pharmaceuticals, medical devices, and cosmetics. The pharmaceutical division represents the production of ethical drugs like the local anesthetic. The medical devices division is engaged in developing devices to aid safe preparation of platelet-poor plasma and platelet concentrate from the sample of blood. The company's suite of cosmetic products comprises of cleansers, creams, and sunscreens.
Contact Information
Website
www.huons.comCorporate Office
- HuonsGlobal Building, A-dong Pangyo I-Square, 17
- 9th Floor, Seongnam, Changeop-ro, Sujeong-gu
- Seongnam, Gyeonggi-do
- South Korea
Corporate Office
- HuonsGlobal Building, A-dong Pangyo I-Square, 17
- 9th Floor, Seongnam, Changeop-ro, Sujeong-gu
- Seongnam, Gyeonggi-do
- South Korea
Huons Global Stock Performance
As of 12-Jun-2025, Huons Global’s stock price is $39.36. Its current market cap is $479M with 12.2M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $39.36 | $39.63 | $15.08 - $40.33 | $479M | 12.2M | 81.1K | $1.53 |
Huons Global Financials Summary
As of 31-Mar-2025, Huons Global has a trailing 12-month revenue of $581M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 639,078 | 671,807 | 453,001 | 348,282 |
| Revenue | 581,169 | 596,188 | 580,045 | 514,167 |
| EBITDA | 94,489 | 96,524 | 119,449 | 30,436 |
| Net Income | 18,661 | 18,902 | 29,358 | (46,632) |
| Total Assets | 967,991 | 954,499 | 1,022,725 | 984,321 |
| Total Debt | 194,087 | 201,896 | 191,562 | 223,541 |
Huons Global Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Huons Global Patents
Huons Global Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240252488-A1 | Mlkl binding or degrading compound and pharmaceutical use thereof | Pending | 28-Sep-2020 | ||
| US-20220249407-A1 | Aqueous antiseptic composition having improved antibacterial persistence comprising chlorhexidine or derivative thereof and fabric type antiseptic comprising same | Pending | 22-Jul-2019 | ||
| US-20220081476-A1 | Method for preparing gly-tb4 | Pending | 07-Aug-2018 | ||
| EP-3835313-A1 | Method for preparing gly-t?4 | Pending | 07-Aug-2018 | ||
| EP-3835313-A4 | Method for preparing gly-t?4 | Pending | 07-Aug-2018 | C07K14/57581 |
Huons Global Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Huons Global Investments & Acquisitions (24)
Huons Global’s most recent deal was a PIPE with PanGen Biotech for . The deal was made on 19-Dec-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PanGen Biotech | 19-Dec-2024 | PIPE | Biotechnology | ||
| Medithings | 03-Jun-2024 | Early Stage VC | Monitoring Equipment | ||
| PanGen Biotech | 27-Mar-2024 | PIPE | Biotechnology | ||
| Genedit | 23-Jan-2024 | Later Stage VC | Biotechnology | ||
| HuonsLifeSciences | 22-Dec-2023 | Merger/Acquisition | Pharmaceuticals |
Huons Global ESG
Risk Overview
Risk Rating
Updated May, 16, 2024
34.36 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile
Pharmaceuticals
Industry
of 844
Rank
Percentile
Pharmaceuticals
Subindustry
of 419
Rank
Percentile
Huons Global Exits (7)
Huons Global’s most recent exit was on 26-Oct-2023 from CellBion. The exit was categorized as with 11 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CellBion | 26-Oct-2023 | Completed |
|
||
| IMGT | 17-Dec-2021 | Completed |
|
||
| IMGT | 30-Nov-2020 | Completed |
|
||
| Medihub | 18-Jun-2020 | Completed |
|
||
| EOFlow | 04-May-2018 | Later Stage VC | Completed |
|
Huons Global Affiliates
Subsidiaries (7)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Food Assemble | Seoul, South Korea | 2018 | |
| HuonsLifeSciences | Seongnam-si, South Korea | 2015 | |
| Humedix | Pangyo, South Korea | 2002 | |
| HuM&C | Incheon, South Korea | 2002 | |
| Huon Spudians | Geumsan-gun, South Korea | 2001 |
Huons Global FAQs
-
When was Huons Global founded?
Huons Global was founded in 1965.
-
Where is Huons Global headquartered?
Huons Global is headquartered in Seongnam, South Korea.
-
What is the size of Huons Global?
Huons Global has 121 total employees.
-
What industry is Huons Global in?
Huons Global’s primary industry is Holding Companies.
-
Is Huons Global a private or public company?
Huons Global is a Public company.
-
What is Huons Global’s stock symbol?
The ticker symbol for Huons Global is 084110.
-
What is the current stock price of Huons Global?
As of 12-Jun-2025 the stock price of Huons Global is $39.36.
-
What is the current market cap of Huons Global?
The current market capitalization of Huons Global is $479M.
-
What is Huons Global’s current revenue?
The trailing twelve month revenue for Huons Global is $581M.
-
What is Huons Global’s annual earnings per share (EPS)?
Huons Global’s EPS for 12 months was $1.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
